Login to Your Account

Cougar's Auerbach Treading Familiar Territory with Puma

By Jennifer Boggs

Friday, October 7, 2011
Puma Biotechnology Inc. padded into the cancer space with a $55 million private placement, a reverse merger and an in-licensing deal that brings it a late-stage breast cancer candidate.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription